Traffic Jam Campaign was founded by Paul Myhill, who also co-founded the predecessor company of LifeVantage Corporation in 2004. In 2006, Mr. Myhill stepped down from all his roles with the Company to focus on charitable endeavors and the Company generously gifted stock to a foundation under Mr. Myhill's trusteeship. In 2011, LifeVantage and many of its Independent Distributors again contributed to Mr. Myhill's charitable organization. Although in recent months, Mr. Myhill's communications in various social media forums created misunderstandings regarding the Company, LifeVantage and Mr. Myhill are pleased to announce that all areas of misunderstanding have been amicably resolved in full.
"We are pleased to make this significant contribution to Traffic Jam Campaign, an organization that is dedicated to improving the lives of children," said Douglas C. Robinson, President and CEO of LifeVantage.
"I express my gratitude to LifeVantage for today's generous contribution as well as its past contributions to further the mission of Traffic Jam Campaign, and I deeply regret any damage or confusion that may have been caused by my public remarks in recent months," Paul Myhill said. "I fully support LifeVantage and its mission, its corporate integrity, its marketing strategy and efforts, and its continued dedication to improving the quality of life for others. I recognize and appreciate the extensive contributions of Dr. Joe McCord and others in the Company in developing, testing and refining Protandim and acknowledge that credit for the current success of LifeVantage and Protandim belongs to many. I am honored to continue as a champion of LifeVantage, but remain primarily focused on my efforts toward helping children around the world."
Mr. Robinson continued, "Mr. Myhill shares our commitment to improving the lives of others and we are pleased to have resolved all of his concerns. LifeVantage remains dedicated to offering science based, research backed products that result in a better quality of life for all. Our flagship product Protandim has been reviewed and validated by investigators at highly respected universities and institutions and continues to be studied worldwide for its ability to reduce oxidative stress, primarily through the activation of Nrf2. We also remain committed to conducting our business, as always, with the highest degree of integrity and transparency."
Mr. Myhill is not a member of LifeVantage management and is not a spokesperson for the Company. All inquiries regarding LifeVantage and Protandim should be directed to the Company.
